Clinical experience with ofloxacin in urinary tract infection.

Abstract	Preliminary data from the U.S. regarding the safety and efficacy of ofloxacin in the treatment of urinary tract infections are presented. Treatment of uncomplicated urinary tract infections with either 200 mg or 300 mg ofloxacin b.i.d. was as effective as treatment with a standard therapy, co-trimoxazole. In another series of patients with underlying abnormalities of the urinary tract, ofloxacin therapy resulted in fewer failures and relapses than co-trimoxazole treatment. Ofloxacin was well tolerated in these studies.
Authors	C E Cox, S V Callery, K J Tack
Journal	Infection (Infection) Vol. 14 Suppl 4 Pg. S303-4 ( 1986) ISSN: 0300-8126 [Print] Germany
PMID	3546150 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References	Anti-Infective Agents Drug Combinations Oxazines Trimethoprim, Sulfamethoxazole Drug Combination Ofloxacin Trimethoprim Sulfamethoxazole
Topics	Anti-Infective Agents (therapeutic use) Clinical Trials as Topic Drug Combinations (therapeutic use) Female Humans Male Ofloxacin Oxazines (therapeutic use) Sulfamethoxazole (therapeutic use) Trimethoprim (therapeutic use) Trimethoprim, Sulfamethoxazole Drug Combination Urinary Tract (abnormalities) Urinary Tract Infections (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!